Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
- 1 April 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (7) , 2869-2872
- https://doi.org/10.1073/pnas.89.7.2869
Abstract
Type IIB von Willebrand disease is an autosomal dominant bleeding disorder characterized by the selective loss of high molecular weight von Willebrand factor (vWF) multimers in plasma, presumably due to their abnormally increased reactivity with platelets. We and others have recently identified a panel of missense mutations clustered in the platelet glycoprotein Ib binding domain of vWF from patients with type IIB von Willebrand disease. We now report functional analysis of one of the most frequent type IIB missense mutations, Arg-543----Trp (vWF R543W). vWF from a human umbilical vein endothelial cell culture heterozygous for the vWF R543W mutation showed markedly increased binding of large vWF multimers to platelets in the presence of a low dose of ristocetin compared to vWF from a normal control culture. Recombinant vWF containing the vWF R543W mutation expressed in COS-7 cells also demonstrated increased binding of large vWF multimers. Mixed multimers obtained by cotransfection of mutant and wild-type cDNAs showed partial dominance of the vWF R543W mutation. Thus these data demonstrate that the vWF R543W mutation alone is sufficient to confer increased binding of large vWF multimers to platelets in a dominant fashion and that no other factors relating to vWF posttranslational processing or secretion in endothelial cells are required for this effect.Keywords
This publication has 37 references indexed in Scilit:
- The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.Journal of Clinical Investigation, 1988
- Luminography – an Alternative Assay for Detection of von Willebrand Factor MultimersThrombosis and Haemostasis, 1988
- Identification of disulfide-bridged substructures within human von Willebrand factorBiochemistry, 1987
- von Willebrand factor and von Willebrand disease.1987
- Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.Journal of Clinical Investigation, 1987
- Type IIB von Willebrand's disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancyBritish Journal of Haematology, 1987
- Localization of binding sites within human von Willebrand factor for monomeric type III collagenBiochemistry, 1986
- Isolation and characterization of a collagen binding domain in human von Willebrand factor.Journal of Biological Chemistry, 1986
- Amino acid sequence of human von Willebrand factorBiochemistry, 1986
- Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.Journal of Clinical Investigation, 1985